Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis
Clinical trial NCT02165345 · COMPLETED
Trial details
- NCT number
- NCT02165345
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-16
- Primary completion
- 2021-11-24
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.